Coordinatore | SOLUCIONES TECNOLOGICAS PARA LA SALUD Y EL BIENESTAR SA
Organization address
address: RONDA AUGUSTE Y LOUIS LUMIERE 23 NAVE 13 contact info |
Nazionalità Coordinatore | Spain [ES] |
Totale costo | 1˙495˙000 € |
EC contributo | 999˙000 € |
Programma | FP7-SME
Specific Programme "Capacities": Research for the benefit of SMEs |
Code Call | FP7-SME-2012 |
Funding Scheme | BSG-SME |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-10-01 - 2014-09-30 |
# | ||||
---|---|---|---|---|
1 |
SOLUCIONES TECNOLOGICAS PARA LA SALUD Y EL BIENESTAR SA
Organization address
address: RONDA AUGUSTE Y LOUIS LUMIERE 23 NAVE 13 contact info |
ES (PATERNA) | coordinator | 242˙950.00 |
2 |
FORUS SRL
Organization address
address: VIA BERNARDO QUARANTA 112 contact info |
IT (NAPOLI) | participant | 295˙950.00 |
3 |
"S.D. INFORMATIKA DOO INFORMATICKI INZENJERING, POSLOVNE USLUGE I TRGOVINA"
Organization address
address: ANDRIJE STAMPARA 8a contact info |
HR (VELIKA GORICA) | participant | 271˙150.00 |
4 |
WEARABLE INFORMATION TECHNOLOGIES SL
Organization address
address: CALLE MUSICO PLASENCIA 1 2 5 contact info |
ES (BENAGUASIL) | participant | 188˙950.00 |
5 |
TRACS SRL
Organization address
address: VIA GIOVANNI XXIII 10 contact info |
IT (NOLA NAPOLI) | participant | 0.00 |
6 |
UNIVERSIDADE DE COIMBRA
Organization address
address: PACO DAS ESCOLAS contact info |
PT (COIMBRA) | participant | 0.00 |
7 |
UNIVERSITAT POLITECNICA DE VALENCIA
Organization address
address: CAMINO DE VERA SN EDIFICIO 3A contact info |
ES (VALENCIA) | participant | 0.00 |
8 |
UNIVERSITY OF ZAGREB FACULTY OF ELECTRICAL ENGINEERING AND COMPUTING
Organization address
address: Unska 3 contact info |
HR (ZAGREB) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Coronary artery disease (CAD) is caused by an accumulation of plaques within the walls of the arteries that supply the myocardium with oxygen and nutrients. After decades of progression, some of these plaques may rupture and along with the activation of the blood clotting system limit blood flow to the myocardium, resulting in an acute coronary syndrome (ACS). This may be either a heart attack (myocardial infarction) meaning that muscle cell necrosis in the affected regions of the myocardium has occurred) or unstable angina (meaning that the patient has persistent or recurrent chest pain at rest but without evidence of myocardial necrosis). Risk factors comprise age, sex, family history but also lifestyle-related aspects such as smoking habits, physical inactivity, overweight/obesity etc. Despite the advantages, utilization of cardiac rehabilitation phase III remains low. Recent research is supportive of the beneficial effects of cardiac rehabilitation in patients with heart failure as well as in older patients. Unfortunately, cardiac rehabilitation continues to be considerably underutilized with poor referral and enrollment rates. Implementing quality performance measures, automated referral systems, and the option of home-based cardiac rehabilitation for some patients may all help to increase participation. In addition, innovative exercise training regimens may help to enhance the beneficial effects of cardiac rehabilitation. HEARTWAYS has the objective to develop an advanced modular solution for supporting cardiac patients in rehabilitation outside a medicalized centre with the aid of wearable sensors and intelligent algorithms that personalize the management and the follow-up for patients and professionals.'
To follow up patients during rehabilitation after cardiovascular disease, European scientists are manufacturing a software and hardware integrated system that monitors physical status of patients at home. Providing an overall assessment of patient progress, the system helps professionals take appropriate disease management actions.